Operating Lease, Right-of-Use Asset in USD of REGENEREX PHARMA, INC. from Q2 2023 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
REGENEREX PHARMA, INC. quarterly Operating Lease, Right-of-Use Asset history and change rate from Q2 2023 to Q3 2025.
  • REGENEREX PHARMA, INC. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $527K, a 15.7% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

REGENEREX PHARMA, INC. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $527K -$98.4K -15.7% 30 Sep 2025 10-Q 17 Nov 2025
Q2 2025 $566K -$154K -21.4% 30 Jun 2025 10-Q 14 Aug 2025
Q1 2025 $604K -$152K -20.1% 31 Mar 2025 10-Q 17 Nov 2025
Q4 2024 $641K -$193K -23.2% 31 Dec 2024 10-Q 07 Feb 2025
Q3 2024 $626K -$278K -30.8% 30 Sep 2024 10-Q 04 Nov 2024
Q2 2024 $720K -$220K -23.4% 30 Jun 2024 10-Q 07 Aug 2024
Q1 2024 $756K 31 Mar 2024 10-K 30 Jun 2025
Q4 2023 $834K 31 Dec 2023 10-Q 05 Feb 2024
Q3 2023 $904K 30 Sep 2023 10-Q 08 Nov 2023
Q2 2023 $940K 30 Jun 2023 10-Q 14 Aug 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.